Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs New Era Energy & Digital Inc. Common Stock (NUAI) Price & Performance

Ionis Pharmaceuticals Inc. Common StockTrade
New Era Energy & Digital Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Ionis Pharmaceuticals Inc. Common Stock vs New Era Energy & Digital Inc. Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while New Era Energy & Digital Inc. Common Stock trades at $3.44 (market cap $518.22M). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 13.6× New Era Energy & Digital Inc. Common Stock's market cap, and New Era Energy & Digital Inc. Common Stock is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and New Era Energy & Digital Inc. Common Stock for 2 Days on average.

IONSNUAI
Market Cap
$7.04B$518.22M
Volume
2,977,4407,267,523
Sector
HealthTechnology
52-Week High
$86.50$8.06
52-Week Low
$42.38$2.37
Typical Hold Time
0 Days2 Days
Enterprise Value
$6.60B$463.57M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ionis Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

New Era Energy & Digital Inc. Common Stock

NUAI trades at $4.29, down 1.15% today, with a bearish technical signal despite recent positive news about a 20-year power deal for its Texas data center project. The company shows severe financial stress with negative margins (-5,985.71% net income margin) and consecutive quarterly losses, though analyst consensus remains bullish with a $10.67 price target. Recent institutional interest includes BlackRock's new stake in Q2 2026.

The stock presents high-risk speculation with potential upside if data center development succeeds, but faces substantial execution and funding risks. Current fundamentals are weak, making it suitable only for risk-tolerant investors betting on future project milestones and hyperscaler partnerships.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IONS
100% Buy0% Sell
Avg holding period · 0 Days
NUAI
100% Buy0% Sell
Avg holding period · 2 Days

About Ionis Pharmaceuticals Inc. Common Stock

Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.

Read more on IONS →

About New Era Energy & Digital Inc. Common Stock

New Era Energy & Digital develops large-scale data centers in energy-rich U.S. markets for AI training and inference workloads. Its Texas Critical Data Centers project in the Permian Basin combines modular deployment with flexible power solutions.

Read more on NUAI →